LATEST DEVELOPMENTS

01/09/14

Dr Steve Bull joins BigDNA Advisory Board

Click here to read more

01/06/14

BigDNA Awarded SE Innovation Support Grant to support new patent submissions

Click here to read more

01/05/14

BigDNA awarded TSB Smart Proof of Market Award

Click here to read more


WELCOME to bigdna ltd

BigDNA Ltd is developing small molecule cancer therapies using a novel delivery and drug activation technology. This proprietary technology aims to increase the therapeutic window of the delivered drug whilst simultaneously reducing non-specific toxicity.

INFORMATION FOR POTENTIAL INVESTORS

BigDNA is a well capitalised company and currently has a diverse, well structured investor portfolio to allow us to develop our small molecule cancer therapies through to phase I trials.

PARTNERING INFORMATION

BigDNA has both a strong, focussed product development program built on key products and an active research arm, whose aim is to develop the core platform technology and to expand the range of cancer therapies delivered and tumor types targeted.

SCIENTIFIC INFORMATION

BigDNA actively seeks to work with academic and industrial partners who may be interested in research and development using our novel platform.